Older Diabetes Drugs Has Similar Effects to Newer Ones

by Medindia Content Team on  July 18, 2007 at 3:27 PM Diabetes News
RSS Email Print This Page Comment bookmark
Font : A-A+

Older  Diabetes Drugs Has Similar Effects  to Newer Ones
A review of published literature about benefits and harms of oral drugs for type 2 diabetes mellitus found that older agents, such as second-generation sulfonylureas and metformin, have similar or superior effects on glycemic control, lipids and other intermediate endpoints compared to newer, more expensive drugs, such as thiazolidinediones, alpha-glucosidase inhibitors and meglitinides.

This is the first systematic review to compare all the drugs with one another, summarizing all available data on the full range of intermediate end-points, such as hemoglobin A1c, lipids, and body weight as well as on adverse effects and macrovascular risks.

Authors say that comparative evidence is urgently needed to guide appropriate therapy, as new oral diabetes drugs continue to emerge on the market.

This review is published early online at HTTP:WWW.ANNALS.ORG/CGI/CONTENT/FULL/0000605-200709180-00178V1

Source: Eurekalert
JAY/M

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetic Retinopathy Drug Toxicity Iodine Deficiency Disorder Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...